Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Very little human research on Larazotide has been registered.
- 10 registered studies in total.
- None are currently enrolling — this research has already happened.
What kind of research
- 10 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 1,211 people took part in those.
How far along it is
- 1 trial has reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 2 have published results in the medical literature that anyone can read.
- The research spans 3 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 10 of 10 trials for Larazotide.
AT1001 for the Treatment of Long COVID
Massachusetts General Hospital
Long COVID · Long COVID-19 · Post Acute COVID-19 Syndrome · Post Acute Sequelae of COVID-19
AT1001 for the Treatment of COVID-19 Related MIS-C
Massachusetts General Hospital
Covid19 · Multisystem Inflammatory Syndrome in Children
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms
9 Meters Biopharma, Inc.
Celiac Disease
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
9 Meters Biopharma, Inc.
Celiac Disease
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
9 Meters Biopharma, Inc.
Celiac Disease
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease
9 Meters Biopharma, Inc.
Celiac Disease
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
9 Meters Biopharma, Inc.
Celiac Disease
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
9 Meters Biopharma, Inc.
Celiac Disease
Safety of Larazotide Acetate in Healthy Volunteers
9 Meters Biopharma, Inc.
Healthy
Safety Study of Larazotide Acetate to Treat Celiac Disease.
9 Meters Biopharma, Inc.
Celiac Disease
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Larazotide is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.